Professor Chloe Orkin appointed new Dean for Healthcare Transformation
Queen Mary University of London is delighted to announce that Professor Chloe Orkin has been appointed as the new Dean for Healthcare Transformation for the Faculty of Medicine and Dentistry.
Chloe is Professor of Infection and Inequities based in the Blizard Institute and Director of the interdisciplinary SHARE Research Collaborative for health equity. She completed her medical degree at the University of Witwatersrand in Johannesburg, South Africa. She has been a Consultant in HIV Medicine at Barts Health NHS Trust since 2003 and became a clinical academic in 2019.
Her research focuses on long-acting HIV therapy for treatment and prevention, mpox and equitable inclusion in research. Chloe was Athena Swan Chair for FMD from 2019-2021 and then Academic EDI Lead from 2021-Jan 2024.
She has also held a number of national and international leadership roles including: clinical advisor to WHO Europe for Mpox (2022-23), Chair of the British HIV Association (2016-19), Medical Women's Federation President (2021-23), IAS Governing Council (2020-24), Scientific Advisor to Medicines Patent Pool (2021-).
She was recently awarded a Member of the Order of the British Empire for service to the National Health Service.
Professor Chloe Orkin said: "I am delighted to take on this role which focuses on the meaningful and systematic integration of the public and people experiencing a range of health conditions across all of our research endeavours"
Professor Sir Mark Caulfield, VP (Health) said: “It is fantastic that Professor Chloe Orkin has agreed to become Dean for Healthcare Transformation to help Medicine and Dentistry at Queen Mary transform lives. Chloe is an amazing leader and has the skills to deliver this ambitious programme, which is an essential element of our 'better health for all' strategy."